![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | EXP | | 6480464 | ethylene dichloride results in decreased expression of CNTN3 mRNA | CTD | PMID:28960355 | 17alpha-ethynylestradiol | decreases expression | ISO | RGD:3253 | 6480464 | Ethinyl Estradiol results in decreased expression of CNTN3 mRNA | CTD | PMID:17557909 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:3253 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CNTN3 mRNA | CTD | PMID:32109520 | 6-propyl-2-thiouracil | decreases expression | ISO | RGD:3253 | 6480464 | Propylthiouracil results in decreased expression of CNTN3 mRNA | CTD | PMID:24780913 | 6-propyl-2-thiouracil | increases expression | ISO | RGD:3253 | 6480464 | Propylthiouracil results in increased expression of CNTN3 mRNA | CTD | PMID:25825206 | acrylamide | decreases expression | ISO | RGD:3253 | 6480464 | Acrylamide results in decreased expression of CNTN3 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases expression | ISO | RGD:732842 | 6480464 | Aflatoxin B1 results in increased expression of CNTN3 mRNA | CTD | PMID:22100608 | aflatoxin B1 | decreases methylation | ISO | RGD:732842 | 6480464 | Aflatoxin B1 results in decreased methylation of CNTN3 gene | CTD | PMID:27153756 | ammonium chloride | affects expression | ISO | RGD:3253 | 6480464 | Ammonium Chloride affects the expression of CNTN3 mRNA | CTD | PMID:16483693 | androgen antagonist | multiple interactions | ISO | RGD:3253 | 6480464 | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CNTN3 mRNA | CTD | PMID:25607892 | Aroclor 1254 | decreases expression | EXP | | 6480464 | Chlorodiphenyl 54% Chlorine results in decreased expression of CNTN3 mRNA | CTD | PMID:23650126 | arsenous acid | decreases expression | ISO | RGD:732842 | 6480464 | Arsenic Trioxide results in decreased expression of CNTN3 mRNA | CTD | PMID:26705709 | belinostat | decreases expression | ISO | RGD:732842 | 6480464 | belinostat results in decreased expression of CNTN3 mRNA | CTD | PMID:26272509 | belinostat | multiple interactions | ISO | RGD:732842 | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of CNTN3 mRNA | CTD | PMID:27188386 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzoapyrene results in increased methylation of CNTN3 exon, Benzoapyrene results in increased methylation of CNTN3 intron | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | affects expression | ISO | RGD:732842 | 6480464 | 7 more ... | CTD | PMID:20382639 | bisphenol A | multiple interactions | ISO | RGD:3253 | 6480464 | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CNTN3 mRNA | CTD | PMID:25607892 | bisphenol A | increases methylation | ISO | RGD:3253 | 6480464 | bisphenol A results in increased methylation of CNTN3 gene | CTD | PMID:28505145 | bisphenol A | decreases expression | ISO | RGD:3253 | 6480464 | bisphenol A results in decreased expression of CNTN3 mRNA | CTD | PMID:25181051 | Butylparaben | multiple interactions | ISO | RGD:3253 | 6480464 | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CNTN3 mRNA | CTD | PMID:25607892 | clorgyline | increases expression | ISO | RGD:732842 | 6480464 | Clorgyline results in increased expression of CNTN3 mRNA | CTD | PMID:19691856 | diarsenic trioxide | decreases expression | ISO | RGD:732842 | 6480464 | Arsenic Trioxide results in decreased expression of CNTN3 mRNA | CTD | PMID:26705709 | Dichloroacetonitrile | affects response to substance | ISO | RGD:732842 | 6480464 | CNTN3 gene SNP affects the susceptibility to dichloroacetonitrile | CTD | PMID:25622337 | dorsomorphin | multiple interactions | ISO | RGD:732842 | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | endosulfan | decreases expression | ISO | RGD:3253 | 6480464 | Endosulfan results in decreased expression of CNTN3 mRNA | CTD | PMID:29391264 | enzacamene | multiple interactions | ISO | RGD:3253 | 6480464 | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CNTN3 mRNA | CTD | PMID:25607892 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of CNTN3 mRNA | CTD | PMID:25629700 | genistein | decreases expression | ISO | RGD:3253 | 6480464 | Genistein results in decreased expression of CNTN3 mRNA | CTD | PMID:12075121 | glycidol | increases expression | ISO | RGD:3253 | 6480464 | glycidol results in increased expression of CNTN3 mRNA | CTD | PMID:24395379 | methylmercury chloride | decreases expression | ISO | RGD:732842 | 6480464 | methylmercuric chloride results in decreased expression of CNTN3 mRNA | CTD | PMID:26272509, PMID:28001369 | methylmercury chloride | multiple interactions | ISO | RGD:732842 | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of CNTN3 mRNA | CTD | PMID:27188386 | mono(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | mono-2-ethylhexylphthalate results in decreased expression of CNTN3 mRNA | CTD | PMID:22401849 | paracetamol | multiple interactions | ISO | RGD:3253 | 6480464 | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CNTN3 mRNA | CTD | PMID:25607892 | paracetamol | decreases expression | ISO | RGD:732842 | 6480464 | Acetaminophen results in decreased expression of CNTN3 mRNA | CTD | PMID:21420995 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:732842 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of CNTN3 mRNA | CTD | PMID:27153767 | progesterone | increases expression | ISO | RGD:732842 | 6480464 | Progesterone results in increased expression of CNTN3 mRNA | CTD | PMID:21795739 | SB 431542 | multiple interactions | ISO | RGD:732842 | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | ISO | RGD:732842 | 6480464 | Silicon Dioxide analog results in increased expression of CNTN3 mRNA | CTD | PMID:23806026 | trichostatin A | increases expression | ISO | RGD:732842 | 6480464 | trichostatin A results in increased expression of CNTN3 mRNA | CTD | PMID:24935251 | triclosan | decreases expression | ISO | RGD:732842 | 6480464 | Triclosan results in decreased expression of CNTN3 mRNA | CTD | PMID:30510588 | valproic acid | decreases expression | ISO | RGD:732842 | 6480464 | Valproic Acid results in decreased expression of CNTN3 mRNA | CTD | PMID:23179753 more ... | valproic acid | increases expression | ISO | RGD:732842 | 6480464 | Valproic Acid results in increased expression of CNTN3 mRNA | CTD | PMID:23179753, PMID:27188386 | vorinostat | multiple interactions | ISO | RGD:732842 | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of CNTN3 mRNA | CTD | PMID:27188386 | |